Depomed Targets Impax, Par Over Generic Epilepsy Drug
Drug company Depomed Inc. on Tuesday sued Impax Laboratories Inc. and Par Pharmaceutical Cos. Inc. in New Jersey federal court, accusing the companies of making a generic version of Depomed's Gralise...To view the full article, register now.
Already a subscriber? Click here to view full article